Medical Journals

Expression and Localization of Parkinson's Disease-associated Leucine-rich Repeat Kinase 2 in the Mouse Brain.

Authors:
  • Higashi Shinji
  • Moore Darren J
  • Colebrooke Rebecca E
  • Biskup Saskia
  • Dawson Valina L
  • Arai Heii
  • Dawson Ted M
  • Emson Piers C

From: Laboratory of Molecular Neuroscience, The Babraham Institute, Babraham, Cambridge, UK.

Journal of neurochemistry

  • Publish Date: Jan 2007
  • ISSN: 0022-3042
  • Volume: 100
  • Issue: 2
  • Pages: 368-81
  • Medium: Print
  • Language: English
  • Citation (JAMA): Higashi Shinji, Moore Darren J, Colebrooke Rebecca E, et al. Expression and Localization of Parkinson's Disease-associated Leucine-rich Repeat Kinase 2 in the Mouse Brain.. J. Neurochem. Jan 2007;100:368-81

Abstract

Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) have been identified as the cause of familial Parkinson’s disease (PD) at the PARK8 locus. To begin to understand the physiological role of LRRK2 and its involvement in PD, we have investigated the distribution of LRRK2 mRNA and protein in the adult mouse brain. In situ hybridization studies indicate sites of mRNA expression throughout the mouse brain, with highest levels of expression detected in forebrain regions, including the cerebral cortex and striatum, intermediate levels observed in the hippocampus and cerebellum, and low levels in the thalamus, hypothalamus and substantia nigra. Immunohistochemical studies demonstrate localization of LRRK2 protein to neurones in the cerebral cortex and striatum, and to a variety of interneuronal subtypes in these regions. Furthermore, expression of LRRK2 mRNA in the striatum of VMAT2-deficient mice is unaltered relative to wild-type littermate controls despite extensive dopamine depletion in this mouse model of parkinsonism. Collectively, our results demonstrate that LRRK2 is present in anatomical brain regions of direct relevance to the pathogenesis of PD, including the nigrostriatal dopaminergic pathway, in addition to other regions unrelated to PD pathology, and is likely to play an important role in the normal function of telencephalic forebrain neurones and other neuronal populations.

Mesh Headings (Keywords): Animals, Biogenic Monoamines, Brain, Cell Count, Gene Expression, Green Fluorescent Proteins, Immunohistochemistry, In Situ Hybridization, Mice, Mice, Mutant Strains, Nerve Tissue Proteins, Protein-Serine-Threonine Kinases, RNA, Messenger, Reverse Transcriptase Polymerase Chain Reaction, Vesicular Monoamine Transport Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 17101029


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.